Connecticut Attorney General William Tong announced four separate settlements with hearing aid companies: Lively Hearing Corporation, Widex USA, Inc., Hark Wellness, Inc., and Wonder Ear, Inc., who marketed their products as “FDA-approved” despite no such approval.
Hearing aids currently do not receive approval from the United States Food and Drug Administration (FDA) in the same manner as new drugs and some medical devices; however, hearing aid manufacturers register their products with the FDA.
Although Congress enacted legislation in 2017 permitting the FDA to create a category of over-the-counter (OTC) hearing aids, the FDA has not yet issued a final rule and no hearing aid suppliers should be marketing their products as OTC or “FDA-approved.”
Recent Posts
Q4 SPAN Meeting to Focus on the ASLP-IC Compact
The American Academy of Audiology’s State Policy Advocate Network (SPAN) will hold its fourth-quarter meeting on October 28, 2026, from 8:00–9:00 pm ET. The meeting…
Tympanostomy Tubes Found in the Middle Ear Space: A Case Report
The placement of pressure equalization (PE) tubes is common procedure and often used for management of otitis media with effusion (OME), recurrent acute otitis media…
Cochlear Implant Satisfaction
Approximately 118,000 adults and 65,000 children in the United States have cochlear implants (CI) (National Institutes of Health, 2021). Most CIs require an external processor,…



